Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Update on Proleukin regulatory status; Photofrin approved in Germany

Aug. 8, 1997

Matrix and Savage enter marketing agreement for AccuSite

Aug. 8, 1997

StressGen and Genzyme announce closing of joint venture

Aug. 8, 1997

Genzyme Transgenics' cancer vaccine elicits immune response in myeloma patients

Aug. 7, 1997

HemoCleanse submits 510(k) for ThermoChem-HT

Aug. 7, 1997

New agent for breast cancer in development at Zenyaku Kogyo

Aug. 7, 1997

Antiproliferative agents from Kirin Brewery

Aug. 6, 1997

Korean researchers isolate aminopeptidase inhibitors from microbial source

Aug. 6, 1997

Novel camptothecin analogues reported by Korean scientists

Aug. 6, 1997

KSA-based cancer vaccine in development

Aug. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...